Compare

BriaCell Therapeutics Corp. vs Immunic, Inc. vs Kiora Pharmaceuticals Inc vs Faeth Therapeutics, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearBriaCell Therapeutics Corp.
BCTX
Immunic, Inc.
IMUX
Kiora Pharmaceuticals Inc
KPRX
Faeth Therapeutics, Inc.
FTH
Year ended2026-07-312025-12-312025-12-312025-12-31
Revenuen/an/a$0n/a
Revenue growth (YoY)n/an/a-100.0%n/a
Gross marginn/an/an/an/a
Operating marginn/an/an/an/a
Net marginn/an/an/an/a
Net income-$34.90M-$97.17M-$10.84M-$21.09M
EPS (Diluted)-$6.97-$0.62-$2.64-$16.72
Operating cash flow-$28.65M-$85.81M-$9.96M-$20.45M
Free cash flow-$28.78M-$85.97M-$10.07M-$20.47M
Cash & equivalents$9.85M$15.48M$8.70M$8.67M
Total assets$23.58M$24.05M$24.25M$22.90M
Total liabilitiesn/a$30.73M$8.13M$4.31M
Shareholders' equity$15.56M-$6.67M$16.13M$18.59M
Return on year-end equity-224.3%n/a-67.2%-113.4%
Shares outstanding8.71M90.15M3.76M1.26M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearBriaCell Therapeutics Corp.Immunic, Inc.Kiora Pharmaceuticals IncFaeth Therapeutics, Inc.
Latestn/an/a$0
Ended 2025-12-31
n/a
1 year earliern/an/a$16.02M
Ended 2024-12-31
n/a
2 years earliern/an/a$0
Ended 2023-12-31
n/a
3 years earliern/an/an/an/a
4 years earliern/an/a$0
Ended 2021-12-31
n/a